Prevalence of concha bullosa in a pediatric population

Jessie G Jiang1, Sarah A Gitomer2, Suhong Tong3

  • 1University of Colorado School of Medicine, 13001 E 17th Pl, Aurora, CO, 80045, USA.

Insights

Concha bullosa (CB), an air-filled middle turbinate, affects nearly 40% of children over 4 years old. This common finding is often linked with nasal septal deviation, particularly on the opposite side.

Area of Science:

  • Pediatric Radiology
  • Otolaryngology
  • Anatomy

Background:

  • Pneumatization of the middle turbinate, known as concha bullosa (CB), is an anatomical variation with limited prevalence data in pediatric populations.
  • CB is clinically significant as it can influence sinonasal anatomy and is frequently associated with congenital nasal septal deviation (SD).

Purpose of the Study:

  • To determine the prevalence of concha bullosa (CB) in a pediatric cohort using head imaging.
  • To describe the common types of CB and its association with nasal septal deviation (SD) in children.

Main Methods:

  • A retrospective review of 695 pediatric CT head scans for trauma (2021-2022) was conducted.
  • Exclusion criteria included facial fractures, sinusitis, syndromes, prior surgery, and sinonasal masses.
  • Two pediatric neuroradiologists assessed 384 eligible scans, defining CB as aeration >50% of the middle turbinate's vertical height.

Main Results:

  • The prevalence of CB was 39.8% in the studied pediatric population, significantly higher in children over 4 years old (p < 0.0001).
  • Lamellar type CB was the most frequent subtype, found in 20.8% of middle turbinates.
  • Nasal septal deviation (SD) was present in 39.2% of patients with CB, predominantly contralateral to the CB.

Conclusions:

  • The prevalence of CB in children falls within the lower range reported for adults.
  • Lamellar CB is the most common type observed in pediatric patients.
  • A significant association exists between CB and contralateral SD, with a positive correlation between the severity of CB and SD.
Abstract

Related Concept Videos

Probability Laws01:49

Probability Laws

Overview
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Toxoplasmosis01:28

Toxoplasmosis

Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...